Ibalizumab Completed Phase 1 Trials for Prevention of Infection With HIV-1 Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT01292174Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers